Accelerated vaccination against HBV infection is an important strategy for the control of HBV infection in prisons;vacinação rápida contra a infecção por VHB é uma estratégia importante para o controle da infecção pelo VHB em presídios

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 44, Issue 5, 2011, Pages 652-653

  Alavian, Seyed Moayed ^a  

^a Baqiyatallah Research Center for Gastroenterology and Liver Disease   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

DRUG DOSE REGIMEN; HEPATITIS B; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION RISK; INFECTION SENSITIVITY; INTRAVENOUS DRUG ABUSE; LETTER; MALE; MEDICAL HISTORY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT SELECTION; PREVALENCE; PRISON; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VIRUS IMMUNITY;

FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; PRISONS;

HEPATITIS B VIRUS;

EID: 81455128138     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822011000500030     Document Type: Letter

References (6)

1. Stief AC, Martins RM, Andrade SM, Pompilio MA, Fernandes SM, Murat PG, et al. Seroprevalence of hepatitis B virus infection and associated factors among prison inmates in state of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop 2010; 43:512-515.
2. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users. Hepat Mon 2011; 11:19-22.
3. Azarkar Z, Sharifzadeh G. Evaluation of the Prevalence of Hepatitis B, Hepatitis C, and HIV in Inmates with Drug-Related Convictions in Birjand, Iran in 2008. Hepat Mon 2010; 10:26-30.
4. Asli AA, Moghadami M, Zamiri N, Tolide-Ei HR, Heydari ST, Alavian SM, et al. Vaccination against hepatitis B among prisoners in Iran: Accelerated vs. classic vaccination. Health Policy 2011; 100:297-304.
5. Jahani MR, Alavian SM, Shirzad H, Kabir A, Hajarizadeh B. Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with "illegal social behaviour". Sex Transm Infect 2005; 81:185.
6. Ataei B, Tayeri K, Kassaeian N, Farajzadegan Z, Babak A. Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors. Hepat Mon 2010; 10:188-192.